Current Study: G44

Purpose:
• To determine how the investigational drug is absorbed, broken down, and removed from the body in volunteers with kidney impairment when compared to volunteers with a normal level of kidney function.
• Information regarding safety and side effects that may occur will also be collected.
• This study is for research purposes only and is not intended to treat your kidney disease.

Method of Administration: Single oral dose of study drug

Investigator: Thomas Marbury, MD

To qualify:

• 18 to 80 years old
• Must have kidney impairment or disease
• May be seeing a nephrologist, have reduced kidney function, or low creatinine clearance and taking medicine such as:

• Procrit®, Epogen®, or Aranesp® for low blood count
or
• PhosLo for high blood phosphorus

Length/Duration:
• 6 days and 5 nights in our research facility
• 1 follow-up phone call

Location: 5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive study medication, study related physical exams and laboratory tests

Compensation Qualified participants will be compensated up to $2,100 for time and travel

Whom to Contact Recruitment Department: 407-240-7876